Bibliographies thématiques / An anticholinergic ipratropium bromidum

Sommaire

Articles de revues
Chapitres de livres
Actes de conférences

Littérature scientifique sur le sujet « An anticholinergic ipratropium bromidum »

Auteur : Grafiati

Publié le 7 juin 2025

Mis à jour le 2 août 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « An anticholinergic ipratropium bromidum ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "An anticholinergic ipratropium bromidum"

Mustafa, Lirim, Hilmi Islami, Mirlinda Havolli, et al. "Effect of Cholinergic Receptor Antagonists on the Potentiation of the Effect of Adenosine Receptor Blockers in People with Bronchial Asthma." Biomedical and Pharmacology Journal 17, no. 2 (2024): 1069–77. http://dx.doi.org/10.13005/bpj/2923.

Texte intégral

Résumé :

Background: The interaction between adenosine receptor blockers and anticholinergic substances in the treatment of bronchial asthma is an area of interest. The efficacy of such combinations in managing bronchial asthma and bronchial hypersensitivity needs to be explored further. Understanding lung function parameters such as airway resistance and intrathoracic gas volume is crucial for evaluating the effects of these medications. Objective: This study aimed to investigate the effect of combining the adenosine receptor blocker, bamifylline, with the anticholinergic substance, ipratropium bromid

Styles APA, Harvard, Vancouver, ISO, etc.

George, Shone, Shiby Sara Shaji, Manish Mohan, M. M. Shahul Hameed, and Jacob Jesurun. "Case report on Ipratropium Bromide induced Anisocoria." Indian Journal of Pharmacy and Pharmacology 10, no. 4 (2024): 323–25. http://dx.doi.org/10.18231/j.ijpp.2023.054.

Texte intégral

Résumé :

Anisocoria or unequal pupil size is an alarming sign of a neurologic emergency, especially when the patient is in a critical care setting. It is important to identify the aetiology of anisocoria and consider drug-induced anisocoria as a possible aetiology after ruling out underlying pathology if any. Ipratropium bromide, an anticholinergic drug, can cause anisocoria. This case report emphasises Ipratropium bromide-induced anisocoria.

Styles APA, Harvard, Vancouver, ISO, etc.

Pant, P., B. Yadav, R. Koju, et al. "Role of tiotropium in chronic obstructive pulmonary disease exacerbation." Journal of Institute of Medicine Nepal 32, no. 2 (2010): 5–10. http://dx.doi.org/10.59779/jiomnepal.496.

Texte intégral

Résumé :

Introduction: Chronic obstructive pulmonary disease (COPD) remains a major public health problem. Many patients suffering from chronic obstructive lungs diseases are of poor economic status, mostly illiterate, therefore has a direct bearing on patient compliance. Tiotropium is a new anticholinergic therapy for chronic obstructive pulmonary disease that differs from ipratropium by its functional relative selectively for musarinic receptor subtypes and which allows single dosing a day. This study presents a cost-effectiveness, efficacy, and side-effects of Ipratropium bromide and Tiotropium in C

Styles APA, Harvard, Vancouver, ISO, etc.

Somand, Heather, and Tami L. Remington. "Tiotropium: A Bronchodilator for Chronic Obstructive Pulmonary Disease." Annals of Pharmacotherapy 39, no. 9 (2005): 1467–75. http://dx.doi.org/10.1345/aph.1e469.

Texte intégral

Résumé :

OBJECTIVE: To review the scientific literature evaluating the efficacy and tolerability of tiotropium bromide, a new bronchodilator indicated for treatment of chronic obstructive pulmonary disease (COPD). DATA SOURCES: Articles were identified through searches of MEDLINE (1966–January 2005) using the key words tiotropium, BA 679 BR, chronic obstructive pulmonary disease, and anticholinergic agents. Additional citations were identified from bibliographies of publications cited. STUDY SELECTION AND DATA EXTRACTION: Experimental and observational studies of tiotropium bromide were selected. Trial

Styles APA, Harvard, Vancouver, ISO, etc.

Mutmainnah, Safina, Yusup Subagio Sutanto, Jatu Aphridasari, and A. Farih Raharjo. "The Effect of Inhaled Ipratropium Bromide as a Premedication For Bronchoscopy on Dyspnea, Cough, and Tracheobronchial Secretion." Jurnal Respirologi Indonesia 43, no. 4 (2023): 255–61. http://dx.doi.org/10.36497/jri.v43i4.256.

Texte intégral

Résumé :

Background: Bronchoscopy is a minimally invasive procedure used for diagnostic examination and intervention of the airways. Patient comfort and cooperation during bronchoscopy are very important because they affect the success and outcome. The sympathetic anticholinergic effect of ipratropium bromide can improve procedure tolerance and airway visualization. This study was conducted to analyze the effect of inhaled ipratropium bromide as a bronchoscopy premedication for the assessment of dyspnea, cough, and tracheobronchial secretion.Methods: This was a clinical study with a quasi-experimental

Styles APA, Harvard, Vancouver, ISO, etc.

Jennings, S. J., J. B. Warren, and N. B. Pride. "Airway caliber and the work of breathing in humans." Journal of Applied Physiology 63, no. 1 (1987): 20–24. http://dx.doi.org/10.1152/jappl.1987.63.1.20.

Texte intégral

Résumé :

Mechanical work rate of breathing was measured in five normal subjects during voluntary eucapnic hyperventilation at rates of approximately 10, 20, 40, 60, and 80 l/min before and after inhalation of 1 mg of ipratropium bromide, an anticholinergic agent. Chest wall recoil pressure was measured over a range of lung volumes in each subject and was used as the reference pressure in the calculation of work rate. There was little change in elastic or resistive work rate at rest when vagal tone was reduced by ipratropium. The mean work at 40, 60, and 80 l/min was 8.9, 17.2, and 34.0 cmH2O.l–1.s befo

Styles APA, Harvard, Vancouver, ISO, etc.

Punin, D. A. "Effect of the combination of a short-acting β2-agonist plus an anticholinergic drug on the efficacy of coronary blood flow measured by applanation tonometry in chronic obstructive pulmonary disease". Russian Medical Inquiry 4, № 4 (2020): 199–206. http://dx.doi.org/10.32364/2587-6821-2020-4-4-199-206.

Texte intégral

Résumé :

Background: bronchodilators are the major class of drugs prescribed for chronic obstructive pulmonary disease (COPD). Meanwhile, treatment strategies for obstructive lung disease using bronchodilators are continually discussed and reviewed, in particular, with regard to their potential effect on cardiovascular system. Aim: to evaluate the effect of the combination of a short-acting β2-agonist plus an anticholinergic medication (fenoterol 50 μg/dose + ipratropium bromide 20 μg/dose, 2 doses) on the efficacy of coronary blood flow in COPD patients. Patients and Methods: spirometry with bronchodi

Styles APA, Harvard, Vancouver, ISO, etc.

Kosirog-Glowacki, Jane L., and Linda R. Bressler. "Cyclophosphamide-Induced Facial Discomfort." Annals of Pharmacotherapy 28, no. 2 (1994): 197–99. http://dx.doi.org/10.1177/106002809402800208.

Texte intégral

Résumé :

OBJECTIVE: To report the occurrence of cyclophosphamide-induced facial discomfort in patients at our institution, to review previous literature reports, and to discuss possible methods of prevention. SETTING: An oncology clinic in a university teaching hospital. PATIENTS: From January 1990 to March 1993, 14 patients experienced uncomfortable sensations of the skin or mucous membranes associated with cyclophosphamide administration. Details pertaining to each patient are described. INTERVENTIONS: Initial interventions included changing the duration of infusion or concentration of cyclophosphami

Styles APA, Harvard, Vancouver, ISO, etc.

Lloberes, P., L. Ramis, JM Montserrat, et al. "Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease." European Respiratory Journal 1, no. 6 (1988): 536–39. http://dx.doi.org/10.1183/09031936.93.01060536.

Texte intégral

Résumé :

This study evaluates the effect of three different bronchodilators (beta 2-adrenergic, anticholinergic and methylxanthine) alone and in randomized sequence, during an exacerbation in thirteen patients with chronic obstructive pulmonary disease. Dose-response curves were obtained for inhaled salbutamol and inhaled ipratropium bromide. The bronchodilator effect of a perfusion of aminophylline was also assessed. When a plateau of bronchodilatation was achieved with one agent, one dose of a second bronchodilator was administered to see whether additional bronchodilation could be achieved. The incr

Styles APA, Harvard, Vancouver, ISO, etc.

SAITO, Hitoshi, Toshihito TSUBOKAWA, and Takehisa SAITO. "Effect of an anticholinergic agent, ipratropium bromide, on nasal ciliary epithelium." Practica Oto-Rhino-Laryngologica 79, no. 1 (1986): 151–59. http://dx.doi.org/10.5631/jibirin.79.151.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Chapitres de livres sur le sujet "An anticholinergic ipratropium bromidum"

Markatos, Sheridan, and Larry Manders. "Anticholinergics." In Basic Anesthesia Review, edited by Alaa Abd-Elsayed. Oxford University PressNew York, 2024. http://dx.doi.org/10.1093/med/9780197584569.003.0246.

Texte intégral

Résumé :

Abstract Anticholinergics block the neurotransmitter acetylcholine in the brain and peripheral tissues. Inhaled anticholinergics, including ipratropium bromide and tiotropium bromide, are important medications in the management of COPD and severe asthma. They have slower onset of action than beta agonists and are therefore used for long-term management rather than acute exacerbations. However, inhaled anticholinergics can be useful in the perioperative setting to mitigate the parasympathetic response to airway instrumentation. This chapter briefly discusses the mechanism of action on anticholi

Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "An anticholinergic ipratropium bromidum"

Jaćović-Knežević, Nataša, and Dragana Atanasijević. "Medicine shortage: Serbian experience." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24069j.

Texte intégral

Résumé :

Background: The unavailability of medicines continues to be on the rise in Europe and it has a tremendous impact on patients. Medicine shortages occur across all healthcare settings and involve both essential life-saving medicines and very commonly used medicines. Medicine shortage means a situation in which the supply of a medicinal product that is authorized and placed on the market in a Member State does not meet demand for that medicinal product at a national level, whatever the cause (Regulation (EU) 2022/123). Medicine shortages can result from different economic, manufacturing, or regul

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!